Anti-Human CSF2/GM-CSF Reference Antibody (KB002)

Description: Anti-Human CSF2/GM-CSF (KB002) (BS11537) is a research-grade recombinant antibody targeting Granulocyte-macrophage colony-stimulating factor. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: Granulocyte-macrophagecolony-stimulatingfactor,Sargramostim,GMCSF,CSF,Colony-stimulatingfactor,CSF2,GM-CSF,Molgramostin
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: KB002
Background: Granulocyte-macrophage colony-stimulating factor (CSF2/GM-CSF) is a ~16 kDa protein. Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes.
Note: For research use only. Not suitable for clinical or therapeutic use.